Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Texas Heart Institute, Rice University, grant, nanotubes, heart, electrical signals
Feature | EP Lab

September 14, 2015 — Texas Heart Institute (THI) announced that it has received a prestigious American Heart Association ...

Home September 14, 2015
Home
News | ECG Monitoring Services

September 10, 2015 — AliveCor Inc. announced significant milestones related to patients with atrial fibrillation (AFib) ...

Home September 10, 2015
Home
News | Atrial Fibrillation

September 1, 2015 — The first-ever two-year outcomes from the Global Anticoagulant Registry in the Field - Atrial ...

Home September 01, 2015
Home
News | Cardiovascular Ultrasound

August 10, 2015 — The Technology Partnership (TTP), a U.K.-based research and product development company, has made ...

Home August 10, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

August 5, 2015 — Boehringer Ingelheim announced the first U.S. patients have been enrolled in two of the company's ...

Home August 05, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

August 4, 2015 — Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events ...

Home August 04, 2015
Home
Feature | Atrial Fibrillation

July 20, 2015 - A new study proves race and gender-related disparities exist in care for patients who have recently been ...

Home July 20, 2015
Home
sentraheart lariet, LAA occlusion, FDA safety alert
Feature | Left Atrial Appendage (LAA) Occluders

July 13, 2015 - The U.S. Food and Drug Administration (FDA) is alerting healthcare providers and patients about reports ...

Home July 13, 2015
Home
Medtronic, CardioInsight, acquisition, ECVUE, cardiac mapping system
Feature | EP Mapping and Imaging Systems

July 1, 2015 - Medtronic has acquired CardioInsight Technologies Inc., a Cleveland-based medical device company that has ...

Home July 01, 2015
Home
News | Left Atrial Appendage (LAA) Occluders

July 1, 2015 - SentreHeart Inc. announced that it has received approval for an Investigational Device Exemption (IDE) ...

Home July 01, 2015
Home
ACC, HRS, SCAI, left atrial appendage occlusion, recommendations
Feature | Left Atrial Appendage (LAA) Occluders

June 30, 2015 - The American College of Cardiology (ACC), Heart Rhythm Society (HRS) and Society for Cardiovascular ...

Home June 30, 2015
Home
News | Thrombectomy Devices

June 11, 2015 - C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device ...

Home June 11, 2015
Home
Blog

There were several technology takeaway messages for the future of electrophysiology (EP) at the Heart Rhythm Society ...

Home May 22, 2015
Home
News

May 21, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the ...

Home May 21, 2015
Home
botox, atrial fibrillation, cardiac surgery, HRS
Feature

May 20, 2015 — A study presented at Heart Rhythm 2015 found that botulinum toxin (botox) injections into epicardial fat ...

Home May 20, 2015
Home
Subscribe Now